Literature DB >> 10026408

Systemic sclerosis revealing T-cell lymphoma.

M Hasegawa1, S Sato, H Sakai, T Ohashi, K Takehara.   

Abstract

We describe a case of systemic sclerosis (SSc) occurring together with malignant lymphoma. A 43-year-old man, who had noticed sclerodactyly 1 month before consultation, was admitted for progressive skin sclerosis on his forearms and chest. SSc was diagnosed. Immediately after admission, skin sclerosis rapidly extended to the neck and trunk, and subcutaneous tumors developed on the neck, chest and back. Skin sclerosis was prominent at the sites where subcutaneous tumors were present. The tumors were diagnosed as non-Hodgkin's lymphoma of T-cell phenotype derived from soft tissue. Following 4 cycles of chemotherapy, he had complete remission and the skin sclerosis remarkably improved. It is possible that cytokines produced by T-cell lymphoma cells were responsible for the development of skin sclerosis in this case.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026408     DOI: 10.1159/000018070

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  12 in total

1.  Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

Authors:  Ami A Shah; Antony Rosen; Laura Hummers; Fredrick Wigley; Livia Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.

Authors:  Ami A Shah; Antony Rosen
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 3.  Cancer and Scleroderma.

Authors:  Emma Weeding; Livia Casciola-Rosen; Ami A Shah
Journal:  Rheum Dis Clin North Am       Date:  2020-06-10       Impact factor: 2.670

4.  Recurrent metastatic breast cancer presenting with paraneoplastic scleroderma.

Authors:  Timothy David Reynolds; Sally Elizabeth Knights
Journal:  BMJ Case Rep       Date:  2014-03-11

5.  Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease.

Authors:  Ami A Shah; Antony Rosen; Laura K Hummers; Betty J May; Alpana Kaushiva; Richard B S Roden; Deborah K Armstrong; Fredrick M Wigley; Livia Casciola-Rosen; Kala Visvanathan
Journal:  Clin Exp Rheumatol       Date:  2017-06-19       Impact factor: 4.473

6.  Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer.

Authors:  Takeru Igusa; Laura K Hummers; Kala Visvanathan; Carrie Richardson; Fredrick M Wigley; Livia Casciola-Rosen; Antony Rosen; Ami A Shah
Journal:  Ann Rheum Dis       Date:  2018-04-20       Impact factor: 19.103

7.  Mechanistic and clinical insights at the scleroderma-cancer interface.

Authors:  Ami A Shah; Livia Casciola-Rosen
Journal:  J Scleroderma Relat Disord       Date:  2017-10-05

Review 8.  Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link.

Authors:  Giordano Egiziano; Sasha Bernatsky; Ami A Shah
Journal:  Best Pract Res Clin Rheumatol       Date:  2016-04-09       Impact factor: 4.098

Review 9.  Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review.

Authors:  Serena Vettori; Stefania Staibano; Massimo Mascolo; Gennaro Ilardi; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2009-10-07       Impact factor: 2.980

Review 10.  Review: cancer-induced autoimmunity in the rheumatic diseases.

Authors:  Ami A Shah; Livia Casciola-Rosen; Antony Rosen
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.